Objectives During routine diagnostic laboratory work, the clinical microbiologist observed an
increase of Acinetobacter baumannii isolates with three different carbapenem susceptibility …

Successful treatment of Acinetobacter baumannii infections require early and appropriate
antimicrobial therapy. One of the first steps in this process is understanding which β …

Thirteen carbapenem-resistant Acinetobacter baumannii isolates, collected in Romania
during 2009–2010, were investigated to identify the mechanism (s) responsible for …

The aim of this study was to identify acquired OXA-type carbapenemases in Acinetobacter
spp. other than Acinetobacter baumannii. From a total of 453 carbapenem-susceptible and …

Background A. baumannii has emerged as an important nosocomial pathogen with an
outstanding ability to acquire multidrug resistant mechanisms. In this study, we investigate …

Antimicrobial resistance in Acinetobacter baumannii is a growing public health concern and
an important pathogen in nosocomial infections. We investigated the genes involved in …

Objectives To investigate the mechanism of ceftazidime resistance in two isogenic
Acinetobacter baumannii strains from the United Arab Emirates. Methods Two A. baumannii …

Carbapenem-resistant Acinetobacter spp. have been increasingly reported worldwide
including Saudi Arabia and Egypt. We examined 64, non-repetitive, Acinetobacter …

A total of 153 non-repeat Acinetobacter spp. clinical isolates obtained in 2015 from Hospital
Sultanah Nur Zahirah (HSNZ) in Terengganu, Malaysia, were characterized. Identification of …

Objective: Acinetobacter baumannii infections are rarely diagnosed in many hospitals in
Nigeria due to a lack of capacity for the identification of the organism in spite of the clinical …